In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new approach that could reshape how this disease is managed. At the center of their ...
In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and mitigate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results